VANI
Vivani Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.49
+7.19%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | — | — | — | — | — |
| Cost of Revenue | 130.0K | 424.0K | — | 357.0K | — |
| Gross Profit | (130.0K) | (424.0K) | — | (357.0K) | — |
| Operating Expenses | |||||
| R&D Expense | 17.9M | 18.1M | 15.7M | 17.0M | 14.2M |
| SG&A Expense | 9.2M | 9.4M | 8.9M | 10.0M | 5.4M |
| General & Admin Expense | 9.2M | 9.4M | 8.9M | 10.0M | 5.4M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | (424.0K) | — | (357.0K) | 1.7M |
| Total Operating Expenses | 27.1M | 27.1M | 24.7M | 26.6M | 21.2M |
| Cost and Expenses | 27.2M | 27.6M | 24.7M | 27.0M | 21.2M |
| Operating Income (EBIT) | (27.2M) | (27.6M) | (24.7M) | (27.0M) | (21.2M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | 913.0K | 947.0K | 1.2M | 1.3M | 7.4M |
| Non-Operating Income (excl Interest) | 95.0K | (947.0K) | (1.2M) | (1.3M) | (1.7M) |
| EBT (Pre-Tax Income) | (26.3M) | (26.6M) | (23.5M) | (25.7M) | (13.9M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (26.3M) | (26.6M) | (23.5M) | (25.7M) | (13.9M) |
| Earnings from Cont. Ops | (26.3M) | (26.6M) | (23.5M) | (25.7M) | (13.9M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (26.3M) | (26.6M) | (23.5M) | (25.7M) | (13.9M) |
| Per Share | |||||
| Basic EPS | ($0.35) | ($0.43) | ($0.43) | ($0.50) | ($0.17) |
| Diluted EPS | ($0.35) | ($0.43) | ($0.43) | ($0.50) | ($0.17) |
| Revenue Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 87.1M | 62.4M | 55.0M | 50.9M | 38.2M |
| Diluted Shares Outstanding | 87.1M | 62.4M | 55.0M | 50.9M | 38.2M |
| Profitability Metrics | |||||
| EBITDA | (27.0M) | (26.2M) | (23.1M) | (25.3M) | (19.2M) |
| D&A | 350.0K | 424.0K | 400.0K | 357.0K | 381.0K |
| EBIT | (27.3M) | (26.6M) | (23.5M) | (25.7M) | (19.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026